Please provide your email address to receive an email when new articles are posted on . The most frequent cause of death in patients with rheumatoid arthritis-associated interstitial lung disease and ...

Lung transplantation is the only curative treatment for IPF, but most patients are ineligible, necessitating focus on slowing disease progression. Nintedanib is recommended for PPF, while pirfenidone ...

Credit: Getty Images. Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with ...

AIM-30 scoring system predicts 30-day mortality risk in IPF patients post-acute exacerbation using eight clinical variables. The system categorizes patients into low, moderate, and high-risk groups, ...

Please provide your email address to receive an email when new articles are posted on . In patients with idiopathic pulmonary fibrosis, antifibrotic treatment may reduce the risk for all-cause ...

Pooled data from three key studies confirms that OFEV® slows disease progression by approximately 50% as measured by decline in forced vital capacity (FVC)*1-8 The pooled analysis also demonstrated ...

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disorder of unknown etiology for which there is no effective therapy. Its course tends to be associated with acute exacerbations, each of ...

Acute exacerbations (AEs) are both common in rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and are a frequent cause of imminent mortality, a retrospective Japanese study suggests.

Background: This study aims to elucidate the capability of periostin (POSTN) as a serum biomarker in diagnosing idiopathic pulmonary fibrosis (IPF), assessing disease severity, and predicting acute ...

Scientists at the University of Illinois at Urbana-Champaign and Mie University in Japan have developed monoclonal antibodies that prevent lung cell death in mouse models for idiopathic pulmonary ...